Cellectis (CLLS) Property, Plant & Equipment (Net) (2013 - 2026)

Cellectis (CLLS) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,981.90 Bn	66,981.62 Bn	-	642,333.36
2	Nanobiotix	1,924.26 Bn	1,924.20 Bn	-	5.32 Mn
3	Akari Therapeutics	975.59 Bn	975.59 Bn	-	-
4	BeOne Medicines	472.11 Bn	467.32 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	121.89 Bn	114.65 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	69.93 Bn	61.18 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.83 Bn	62.83 Bn	-	-
8	Argenx Se	55.82 Bn	50.63 Bn	1.41 Bn	1.96 Bn
9	Revolution Medicines	37.49 Bn	37.49 Bn	-	31.48 Mn
10	Cellectis	285.51 Mn	99.84 Mn	-	37.40 Mn

Download Data